|
EP3610885A1
|
|
Composition for the intravitreal administration of therapeutic protein
|
|
PL427987A1
|
|
Method for modifying arsenic concentration
|
|
PL427907A1
|
|
Method of producing electrodes for electrochemical detection of β-glucan
|
|
PL427811A1
|
|
Method for assessing the antioxidative capacity of plant, cosmetic, food or plasma substances and preparations using ABTS reagent spectrophotometry
|
|
PL427370A1
|
|
Method of determining the risk of death in a patient diagnosed with laryngeal cancer
|
|
PL426467A1
|
|
Liquid for rinsing root canals and method of producing it
|
|
PL418697A1
|
|
Method for determination of anti-oxidative activity, preferably of edible fats
|
|
PL418696A1
|
|
Modified edible oil with improved anti-oxidative properties and its applications
|
|
PL418690A1
|
|
Method for detection of anxiety disorders with anxiety attacks
|
|
PL417959A1
|
|
Method for determining the level of risk to contract pulmonary carcinoma
|
|
PL417957A1
|
|
Method for determining the risk of prostatic carcinoma
|
|
PL417958A1
|
|
Method and the system for detecting high risk of ovarian carcinoma in the Polish population
|
|
PL417960A1
|
|
Method for detecting decreased risk of falling ill with cancer
|
|
PL417961A1
|
|
Iron concentration in the blood as the marker for prostatic carcinoma
|
|
PL417681A1
|
|
Method, application and a set for detecting increased high-risk breast cancer by examination of SERPINI2 gene mutations
|
|
PL417682A1
|
|
Concentration of selenium in a body as a prognostic marker in persons with larynx cancer
|
|
PL417683A1
|
|
Diagnostic test for detecting the Lynch syndrome, preferably in the Polish population
|
|
PL413907A1
|
|
Method for detecting genetically conditioned predisposition to the colonic carcinoma
|
|
PL411632A1
|
|
Method, application and a set for detecting high risk breast cancer by examination of RECQL gene mutations
|
|
PL410186A1
|
|
Method, application and a set for detecting high risk breast cancer with bad prognosis
|
